Targeting neuropilin-1 with single domain antibodies modulates the myeloid tumor compartment and reduces cancer progression

Research output: Unpublished contribution to conferencePoster

Fingerprint

Dive into the research topics of 'Targeting neuropilin-1 with single domain antibodies modulates the myeloid tumor compartment and reduces cancer progression'. Together they form a unique fingerprint.

Medicine & Life Sciences